Lorcaserin affinity for the 5-HT2c 100 times higher than the 5-HT2B (valvular heart disease risk),it has good safety,it is the first FDA-approved weight-loss drug after 1999 .
Ukusondelana kwe-Raw Lorcaserin powder kwe-5-HT2c 5 izikhathi eziphakeme kune-2-HT100B (ingozi yesifo senhliziyo ye-valvular), inokuphepha okuhle, iyisidakamizwa sokuqala sokulahlekelwa isisindo esivunyelwe yi-FDA ngemuva kuka-5.